Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN86567908
ISRCTN86567908Completed未知

A randomised trial of a patient-centred strategy to facilitate transition of breast cancer survivors' routine Follow-UP from specialist to primary care

Canadian Breast Cancer Research Alliance/National Cancer Institute of Canada0 sites400 target enrollmentStarted: March 5, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
400
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24326740

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • •1. Women diagnosed with invasive breast cancer
  • •2. Stage I, II, or IIIa having completed primary treatment
  • •3. There is no evidence of recurrence; and
  • •4. Patient's surgeon agrees to transfer follow-up care to the Family Practitioner (FP)

Exclusion Criteria

  • •1. Primary treatment (surgery, chemotherapy, radiotherapy) not completed at least three months previously, except for continued use of tamoxifen or an aromatase inhibitor
  • •2. On herceptin or a potential candidate for herceptin (patients will become eligible following completion of herceptin therapy if ready for transition to primary care for routine follow-up)
  • •3. Under investigation for possible recurrence (patients will become eligible if recurrence is ruled out)
  • •4. Does not have a community-based FP to provide care (we will monitor the frequency with which patients are excluded because of this factor)
  • •5. The patients' FP already has a patient enrolled in the trial (to avoid contamination)
  • •6. Unable to comply with study protocol including completion of questionnaires
  • •7. Previously enrolled in a study requiring ongoing follow-up by a cancer specialist; or
  • •8. Actively followed by a cancer specialist for another primary cancer

Investigators

Sponsor
Canadian Breast Cancer Research Alliance/National Cancer Institute of Canada

Similar Trials

Completed
Not Applicable
A randomised, controlled, factorial pilot study investigating omacor and/or fluvastatin in patients with chronic hepatitis C who have not responded to standard combination anti-viral therapyChronic viral hepatitis
ISRCTN48248159ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)72
Completed
Not Applicable
Effectiveness of preventive support groups for children (aged 8-12) of mentally ill or addicted parentsMental health problems in children at riskMental and Behavioural DisordersBehavioural and emotional disorders with onset usually occurring in childhood and adolescence
ISRCTN48032451The Netherlands Organisation for Health Research and Development [ZonMw] (Netherlands)228
Completed
Phase 2
The clinical effectiveness, safety and cost effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitisOphthalmologyEye DiseasesIridocyclitis
ISRCTN10065623niversity Hospitals Bristol NHS Foundation Trust (UK)90
Completed
Not Applicable
urse vs patient management of postop pai
ISRCTN10868989orfolk and Norwich University Hospital NHS Trust (UK)144
Completed
Phase 3
nited Kingdom childhood Acute Lymphoblastic Leukaemia Randomised Trial 2003eukaemiaLymphoid leukaemiaCancer
ISRCTN07355119niversity of Sheffield (UK)2,500